Skip to content
drillr.ai
Sign up

4884.T

Kringle Pharma,Inc.

グロース · 医薬品 · 医薬品 · JP

JPY 415.00
−5.47%
Ask drillr

  • Sep 4, 2026, 05:09 UTC

    Kringle Pharma announced a joint research agreement with Yokohama City University to evaluate the efficacy of hepatocyte growth factor for chemotherapy-induced peripheral neuropathy.

    Source: